Latest recalls
FDAClass IISeptember 2, 2026

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg)

Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), packaged in a) 90-count bottles (NDC 16729-451-15) and b) 1000-count bottles, (NDC 16729-451-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Why it was recalled

Subpotent Drug

What to do

The recall is ongoing. Follow the firm and FDA instructions.

Affected products and identifiers

a) Lot #: D2402186, Exp. Date 09/30/2026. b) Lot #: D2402019, Exp. Date 08/31/2026; D2402094, Exp. Date 09/30/2026; D2500022, D2500023, D2500021, Exp. Date 12/31/2026. — N/A

Record details

ACCORD HEALTHCARE, INC. — Nationwide within the United States

Open FDA enforcement record